COGHE, GIANCARLO
 Distribuzione geografica
Continente #
EU - Europa 226.190
NA - Nord America 6.714
AS - Asia 2.282
SA - Sud America 301
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 5
Totale 235.554
Nazione #
IT - Italia 224.341
US - Stati Uniti d'America 6.612
CN - Cina 1.022
SG - Singapore 887
SE - Svezia 478
UA - Ucraina 405
DE - Germania 321
BR - Brasile 249
FI - Finlandia 197
GB - Regno Unito 188
VN - Vietnam 122
FR - Francia 83
CA - Canada 74
KR - Corea 42
IN - India 39
ES - Italia 25
HK - Hong Kong 23
NL - Olanda 23
ZA - Sudafrica 23
MX - Messico 21
PL - Polonia 20
AR - Argentina 19
CZ - Repubblica Ceca 19
IQ - Iraq 17
JP - Giappone 17
EC - Ecuador 16
RU - Federazione Russa 16
TR - Turchia 16
BD - Bangladesh 14
BE - Belgio 14
EU - Europa 14
IR - Iran 13
LT - Lituania 11
AT - Austria 10
IL - Israele 10
SA - Arabia Saudita 9
MA - Marocco 8
CH - Svizzera 7
DZ - Algeria 6
PK - Pakistan 6
UY - Uruguay 6
UZ - Uzbekistan 6
AU - Australia 5
AZ - Azerbaigian 5
RO - Romania 5
EG - Egitto 4
HU - Ungheria 4
TH - Thailandia 4
VE - Venezuela 4
CO - Colombia 3
DK - Danimarca 3
ID - Indonesia 3
IE - Irlanda 3
KE - Kenya 3
KG - Kirghizistan 3
MD - Moldavia 3
NP - Nepal 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CL - Cile 2
CR - Costa Rica 2
EE - Estonia 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
PE - Perù 2
TN - Tunisia 2
AL - Albania 1
BT - Bhutan 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MC - Monaco 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 235.554
Città #
Cagliari 220.165
Uta 3.779
Fairfield 719
Ashburn 712
Woodbridge 528
Singapore 409
Chandler 406
Houston 357
Dallas 351
Seattle 297
Wilmington 293
Nyköping 277
Ann Arbor 269
Boardman 249
Beijing 222
Cambridge 205
Jacksonville 173
Dearborn 154
New York 138
Helsinki 121
Munich 110
Nanjing 107
Santa Clara 100
Los Angeles 98
Shanghai 89
Boston 74
The Dalles 65
Milan 45
Buffalo 43
Hefei 42
Seoul 42
Atlanta 38
Nanchang 36
Redwood City 36
Ho Chi Minh City 35
Norwalk 35
Guangzhou 33
San Diego 32
Toronto 32
Washington 32
Sassari 31
São Paulo 31
Shenyang 30
Dong Ket 28
Hebei 25
Jiaxing 25
London 25
Hangzhou 24
Phoenix 21
Rome 21
Verona 21
Hanoi 18
Warsaw 18
Brooklyn 17
Changsha 17
Hong Kong 17
Tianjin 17
Chicago 16
Montreal 16
Tokyo 16
Columbus 15
Johannesburg 15
Orem 15
Denver 14
Düsseldorf 14
Stockholm 14
Council Bluffs 13
Kunming 13
Zhengzhou 13
Augusta 12
Brno 12
Jinan 12
Mountain View 12
Turku 12
Mexico City 11
Frankfurt am Main 10
Poplar 10
Taizhou 10
Amsterdam 9
Brussels 9
Ningbo 9
Redondo Beach 9
San Jose 9
Chennai 8
Detroit 8
Rio de Janeiro 8
San Francisco 8
Wuhan 8
Chengdu 7
Curitiba 7
Lauterbourg 7
Leawood 7
Nuremberg 7
Redmond 7
Domusnovas 6
Florence 6
Haiphong 6
Newark 6
Ottawa 6
Portsmouth 6
Totale 231.772
Nome #
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.914
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.900
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.537
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.461
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.442
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.277
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.180
Overexpression of the cytokine BAFF and autoimmunity risk 4.057
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 3.989
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 3.966
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.881
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.868
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.833
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.810
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.800
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.769
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.762
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.695
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.650
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.629
Walking improvements with nabiximols in patients with multiple sclerosis 3.623
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.589
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.558
Texting while walking differently alters gait patterns in people with multiple sclerosis and healthy individuals 3.555
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.548
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.541
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.471
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.381
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.375
Impact of the media on future hope in multiple sclerosis 3.353
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.273
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.265
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.254
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.217
Oral agents in multiple sclerosis 3.180
Influence of treatments in multiple sclerosis disability: a cohort study 3.148
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.136
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.072
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.032
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.001
Smoothness of gait, but not spatio-temporal parameters, are altered in early stages of Multiple Sclerosis 2.978
Refining the connection between gait and cognition: training the body to improve the brain 2.943
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.941
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.940
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.927
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.903
Validation of the Arm Profile Score in assessing upper limb functional impairments in people with multiple sclerosis 2.867
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.833
Hourly trends of physical activity in people with Multiple Sclerosis 2.816
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.779
Do gait patterns differ in men and women with multiple sclerosis? 2.765
Postural adaptation during a Nintendo Wii balance training 2.639
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.611
Are static and dynamic balance abilities correlated in people with Multiple Sclerosis? 2.570
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.528
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.408
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.308
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.305
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.295
The cohort of the multiple sclerosis center of Cagliari 2.284
Induction and escalation therapies in multiple sclerosis 2.253
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.195
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 2.005
Epidemiology of multiple sclerosis in south-western Sardinia 1.900
Kinematic analysis of “hand-to-mouth” task in people with Multiple Sclerosis 1.873
The impact of deep grey matter volume on cognition in Multiple Sclerosis 1.782
Evaluation of FMR1 gene premutation in Sardinians multiple sclerosis 1.716
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 1.675
Characterization of gait abnormalities in individuals affected by multiple sclerosis by means of the Gait Profile Score 1.619
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 1.572
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis 1.533
Monoclonal antibodies: a target therapy for multiple sclerosis 1.453
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study 1.393
Characterization of gait patterns of people with Multiple Sclerosis by means of the GPS index 1.118
Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis 1.101
Kinematic Analysis of Lower Limb Joint Asymmetry during Gait in People with Multiple Sclerosis 1.093
Gait initiation evaluation in multiple sclerosis 1.081
Postural sway analysis as tool to assess balance impairments in individuals with multiple sclerosis 1.039
Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study 991
Inter-joint coordination during gait in people with multiple sclerosis: A focus on the effect of disability 866
Use of wrist-worn accelerometers to quantify bilateral upper limb activity and asymmetry under free-living conditions in people with multiple sclerosis 824
null 756
Evolution of teriflunomide use in multiple sclerosis: A real-world experience 605
Men and women with Multiple Sclerosis exhibit different kinematics of gait: implications for rehabilitation 551
Role of geo-chemical environmental factors in multiple sclerosis distribution in the south-western Sardinia 278
Evaluation of the Metabolomics Profile in Charcot–Marie–Tooth (CMT) Patients: Novel Potential Biomarkers 50
Totale 235.954
Categoria #
all - tutte 271.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 271.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126.987 0 0 0 0 0 6.973 4.108 4.196 2.319 3.758 3.581 2.052
2021/202211.762 1.662 798 499 1.028 1.015 629 570 528 1.125 1.191 1.418 1.299
2022/202314.837 1.553 2.435 2.185 1.240 1.124 1.422 563 970 785 794 1.135 631
2023/202413.010 781 842 497 853 1.212 2.244 1.346 1.335 617 891 1.239 1.153
2024/202535.965 11.995 11.710 3.960 2.372 1.358 1.544 2.034 136 232 210 199 215
2025/20262.957 563 265 591 552 560 426 0 0 0 0 0 0
Totale 235.954